Allosteric Modulation of Ligand Gated Ion Channels by Ivermectin
Tóm tắt
Từ khóa
Tài liệu tham khảo
ADELSBERGER H, LEPIER A, DUDEL J: Activation of rat recombinant alpha(1)beta(2)gamma(2S) GABA(A) receptor by the insecticide ivermectin. Eur J Pharmacol 394: 163-170, 2000.
AGBOH KC, WEBB TE, EVANS RJ, ENNION SJ: Functional characterization of a P2X receptor from Schistosoma mansoni. J Biol Chem 279: 41650-41657, 2004.
AHERN GP, JUNANKAR PR, PACE SM, CURTIS S, MOULD JA, DULHUNTY AF: Effects of ivermectin and midecamycin on ryanodine receptors and the Ca2+-ATPase in sarcoplasmic reticulum of rabbit and rat skeletal muscle. J Physiol 514: 313-326, 1999.
BARRANTES FJ: Structural basis for lipid modulation of nicotinic acetylcholine receptor function. Brain Res Brain Res Rev 47: 71-95, 2004.
BASSISSI MF, ALVINERIE M, LESPINE A: Macrocyclic lactones: distribution in plasma lipoproteins of several animal species including humans. Comp Biochem Physiol C Toxicol Pharmacol 138: 437-444, 2004.
BRAKE AJ, WAGENBACH MJ, JULIUS D: New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature 371: 519-523, 1994.
CHIARA DC, DOSTALOVA Z, JAYAKAR SS, ZHOU X, MILLER KW, COHEN JB: Mapping general anesthetic binding site(s) in human alpha1beta3 gamma-aminobutyric acid type A receptors with [(3)H]TDBzl-etomidate, a photoreactive etomidate analogue. Biochemistry 51: 836-847, 2012.
CODDOU C, STOJILKOVIC SS, HUIDOBRO-TORO JP: Allosteric modulation of ATP-gated P2X receptor channels. Rev Neurosci 22: 335-354, 2011.
COLLINS T, MILLAR NS: Nicotinic acetylcholine receptor transmembrane mutations convert ivermectin from a positive to a negative allosteric modulator. Mol Pharmacol 78: 198-204, 2010.
CULLY DF, VASSILATIS DK, LIU KK, PARESS PS, VAN DER PLOEG LH, SCHAEFFER JM, ARENA JP: Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegans. Nature 371: 707-711, 1994.
CULLY DF, PARESS PS, LIU KK, SCHAEFFER JM, ARENA JP: Identification of a Drosophila melanogaster glutamate-gated chloride channel sensitive to the antiparasitic agent avermectin. J Biol Chem 271: 20187-20191, 1996.
CUPP EW, SAUERBREY M, RICHARDS F: Elimination of human onchocerciasis: history of progress and current feasibility using ivermectin (Mectizan((R))) monotherapy. Acta Trop 120 (Suppl 1): S100-S108, 2011.
DENT JA, DAVIS MW, AVERY L: avr-15 encodes a chloride channel subunit that mediates inhibitory glutamatergic neurotransmission and ivermectin sensitivity in Caenorhabditis elegans. Embo J 16: 5867-5879, 1997.
DENT JA, SMITH MM, VASSILATIS DK, AVERY L: The genetics of ivermectin resistance in Caenorhabditis elegans. Proc Natl Acad Sci USA 97: 2674-2679, 2000.
DUCE IR, SCOTT RH: Actions of dihydroavermectin B1a on insect muscle. Br J Pharmacol 85: 395-401, 1985.
DUFOUR V, BEECH RN, WEVER C, DENT JA, GEARY TG: Molecular Cloning and Characterization of Novel Glutamate-Gated Chloride Channel Subunits from Schistosoma mansoni. PLoS Pathog 9: e1003586, 2013.
HATTORI M, GOUAUX E: Molecular mechanism of ATP binding and ion channel activation in P2X receptors. Nature 485: 207-212, 2012.
HIBBS RE, GOUAUX E: Principles of activation and permeation in an anion-selective Cys-loop receptor. Nature 474: 54-60, 2011.
HUANG J, CASIDA JE: Avermectin B1a binds to high- and low-affinity sites with dual effects on the gamma-aminobutyric acid-gated chloride channel of cultured cerebellar granule neurons. J Pharmacol Exp Ther 281: 261-266, 1997.
JELINKOVA I, YAN Z, LIANG Z, MOONAT S, TEISINGER J, STOJILKOVIC SS, ZEMKOVA H: Identification of P2X(4) receptor-specific residues contributing to the ivermectin effects on channel deactivation. Biochem Biophys Res Commun 349: 619-625, 2006.
JELINKOVA I, VAVRA V, JINDRICHOVA M, OBSIL T, ZEMKOVA HW, ZEMKOVA H, STOJILKOVIC SS: Identification of P2X(4) receptor transmembrane residues contributing to channel gating and interaction with ivermectin. Pflugers Arch 456: 939-950, 2008.
KAWATE T, MICHEL JC, BIRDSONG WT, GOUAUX E: Crystal structure of the ATP-gated P2X(4) ion channel in the closed state. Nature 460: 592-598, 2009.
KEANE J, AVERY L: Mechanosensory inputs influence Caenorhabditis elegans pharyngeal activity via ivermectin sensitivity genes. Genetics 164: 153-162, 2003.
KHAKH BS, PROCTOR WR, DUNWIDDIE TV, LABARCA C, LESTER HA: Allosteric control of gating and kinetics at P2X(4) receptor channels. J Neurosci 19: 7289-7299, 1999.
KORINEK M, KAPRAS V, VYKLICKY V, ADAMUSOVA E, BOROVSKA J, VALES K, STUCHLIK A, HORAK M, CHODOUNSKA H, VYKLICKY L JR: Neurosteroid modulation of N-methyl-D-aspartate receptors: molecular mechanism and behavioral effects. Steroids 76: 1409-1418, 2011.
KRAUSE RM, BUISSON B, BERTRAND S, CORRINGER PJ, GALZI JL, CHANGEUX JP, BERTRAND D: Ivermectin: a positive allosteric effector of the alpha7 neuronal nicotinic acetylcholine receptor. Mol Pharmacol 53: 283-294, 1998.
KRUSEK J, ZEMKOVÁ H: Effect of ivermectin on gamma-aminobutyric acid-induced chloride currents in mouse hippocampal embryonic neurones. Eur J Pharmacol 259: 121-128, 1994.
LEE SY, MACKINNON R: A membrane-access mechanism of ion channel inhibition by voltage sensor toxins from spider venom. Nature 430: 232-235, 2004.
LERCHNER W, XIAO C, NASHMI R, SLIMKO EM, VAN TRIGT L, LESTER HA, ANDERSON DJ: Reversible silencing of neuronal excitability in behaving mice by a genetically targeted, ivermectin-gated Cl- channel. Neuron 54: 35-49, 2007.
LI GD, CHIARA DC, SAWYER GW, HUSAIN SS, OLSEN RW, COHEN JB: Identification of a GABAA receptor anesthetic binding site at subunit interfaces by photolabeling with an etomidate analog. J Neurosci 26: 11599-11605, 2006.
LIN D, BOYLE MP, DOLLAR P, LEE H, LEIN ES, PERONA P, ANDERSON DJ: Functional identification of an aggression locus in the mouse hypothalamus. Nature 470: 221-226, 2011.
LORCA RA, CODDOU C, GAZITUA MC, BULL P, ARREDONDO C, HUIDOBRO-TORO JP: Extracellular histidine residues identify common structural determinants in the copper/zinc P2X2 receptor modulation. J Neurochem 95: 499-512, 2005.
LYNAGH T, LYNCH JW: An improved ivermectin-activated chloride channel receptor for inhibiting electrical activity in defined neuronal populations. J Biol Chem 285: 14890-14897, 2010.
LYNAGH T, LYNCH JW: Molecular mechanisms of Cys-loop ion channel receptor modulation by ivermectin. Front Mol Neurosci 5: 60, 2012.
LYNAGH T, WEBB TI, DIXON CL, CROMER BA, LYNCH JW: Molecular determinants of ivermectin sensitivity at the glycine receptor chloride channel. J Biol Chem 286: 43913-43924, 2011.
MARTIN RJ, PENNINGTON AJ: A patch-clamp study of effects of dihydroavermectin on Ascaris muscle. Br J Pharmacol 98: 747-756, 1989.
MILLAR NS, DENHOLM I: Nicotinic acetylcholine receptors: targets for commercially important insecticides. Invert Neurosci 7: 53-66, 2007.
MILLER PS, SMART TG: Binding, activation and modulation of Cys-loop receptors. Trends Pharmacol Sci 31: 161-174, 2010.
NJUE AI, HAYASHI J, KINNE L, FENG XP, PRICHARD RK: Mutations in the extracellular domains of glutamate-gated chloride channel alpha3 and beta subunits from ivermectin-resistant Cooperia oncophora affect agonist sensitivity. J Neurochem 89: 1137-1147, 2004.
NORHOLM AB, FRANCOTTE P, OLSEN L, KRINTEL C, FRYDENVANG K, GOFFIN E, CHALLAL S, DANOBER L, BOTEZ-POP I, LESTAGE P, PIROTTE B, KASTRUP JS: Synthesis, pharmacological and structural characterization, and thermodynamic aspects of novel GluA2 positive allosteric modulators with a 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide scaffold. J Med Chem 56: 8736-8745, 2013.
OLSEN JA, KASTRUP JS, PETERS D, GAJHEDE M, BALLE T, AHRING PK: Two distinct allosteric binding sites at alpha4beta2 nicotinic acetylcholine receptors revealed by NS206 and NS9283 give unique insights to binding-activity associated linkage at Cys-loop receptors. J Biol Chem 288: 35997-36006, 2013.
PISTIS M, BELELLI D, PETERS JA, LAMBERT JJ: The interaction of general anaesthetics with recombinant GABAA and glycine receptors expressed in Xenopus laevis oocytes: a comparative study. Br J Pharmacol 122: 1707-1719, 1997.
PRIEL A, SILBERBERG SD: Mechanism of ivermectin facilitation of human P2X4 receptor channels. J Gen Physiol 123: 281-293, 2004.
RALEVIC V, BURNSTOCK G: Receptors for purines and pyrimidines. Pharmacol Rev 50: 413-492, 1998.
ROBERTSON B: Actions of anaesthetics and avermectin on GABAA chloride channels in mammalian dorsal root ganglion neurones. Br J Pharmacol 98: 167-176, 1989.
SHAN Q, HADDRILL JL, LYNCH JW: Ivermectin, an unconventional agonist of the glycine receptor chloride channel. J Biol Chem 276: 12556-12564, 2001.
SIEGHART W: Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes. Pharmacol Rev 47: 181-234, 1995.
SIGEL E, BAUR R: Effect of avermectin B1a on chick neuronal gamma-aminobutyrate receptor channels expressed in Xenopus oocytes. Mol Pharmacol 32: 749-752, 1987.
SILBERBERG SD, LI M, SWARTZ KJ: Ivermectin interaction with transmembrane helices reveals widespread rearrangements during opening of P2X receptor channels. Neuron 54: 263-274, 2007.
SLIMKO EM, MCKINNEY S, ANDERSON DJ, DAVIDSON N, LESTER HA: Selective electrical silencing of mammalian neurons in vitro by the use of invertebrate ligand-gated chloride channels. J Neurosci 22: 7373-7379, 2002.
TAYLOR HR, PACQUE M, MUNOZ B, GREENE BM: Impact of mass treatment of onchocerciasis with ivermectin on the transmission of infection. Science 250: 116-118, 1990.
VALERA S, HUSSY N, EVANS RJ, ADAMI N, NORTH RA, SURPRENANT A, BUELL G: A new class of ligand-gated ion channel defined by P2x receptor for extracellular ATP. Nature 371: 516-519, 1994.
VAVRA V, BHATTACHARYA A, ZEMKOVA H: Facilitation of glutamate and GABA release by P2X receptor activation in supraoptic neurons from freshly isolated rat brain slices. Neuroscience 188: 1-12, 2011.
YAMAGUCHI M, SAWA Y, MATSUDA K, OZOE F, OZOE Y: Amino acid residues of both the extracellular and transmembrane domains influence binding of the antiparasitic agent milbemycin to Haemonchus contortus AVR-14B glutamate-gated chloride channels. Biochem Biophys Res Commun 419: 562-566, 2012.